Back to LMR Partners LLP LMR Partners LLP

IBRXIBRX

2 quarters

Position history for LMR Partners LLPLMR Partners LLP's holdings in IMMUNITYBIO INC

No. LMR Partners exited its IBRX (Immunitybio) position in Q1 2025. Its Q4 2024 13F listed 47,402 shares worth $121,349. LMR Partners first reported IBRX in Q4 2024 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$121,349

Total Shares Change

-47,402

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%$3.01
0
2024-Q4
New
47,402
—
$121,3490.0%$2.56
31

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used